Showing 461 - 480 results of 1,475 for search '"cancer"', query time: 0.08s Refine Results
  1. 461

    Development and validation of the respite care model for adults with cancer in Iran: study protocol for a multimethod research project by Vahid Pakpour, Fatemeh Sadeghi-Ghyassi, Azad Rahmani, Nasrin Kheibar, Maryam Rassouli

    Published 2025-02-01
    “…Introduction The primary caregivers of patients with cancer, especially in advanced stages, experience significant physical and emotional strain and require comprehensive support. …”
    Get full text
    Article
  2. 462
  3. 463

    Korean patients with hereditary cancer: a prospective multicentre cohort study protocol exploring psychosocial and health outcomes by Boyoung Park, Sun-young Kong, Dongju Won, Jong Eun Park, Jun-Kyu Kim, Mi-Ae Jang, Jung-Sook Ha, Kyoung-Bo Kim

    Published 2025-02-01
    “…Introduction Although genetic testing for hereditary cancers is increasing, data on health attitudes based on genetic pathogenicity are limited. …”
    Get full text
    Article
  4. 464
  5. 465
  6. 466
  7. 467

    O QUE SIGNIFICA COMPARTILHAR GENE? Uma discussão acerca das implicações sociais da genética do câncer by Mette Nordahl Svendsen

    Published 2014-04-01
    “…O artigo que segue trata das implicações sociais da genética do câncer. Resultado de um trabalho de campo realizado em instituições de aconselhamento genético na Dinamarca, ele procura indicar o modo pelo qual um novo conjunto de práticas médicas e de aparatos tecno-científicos vem promovendo uma nova compreensão do corpo e das relações parentais. …”
    Get full text
    Article
  8. 468

    Machine learning identifies the association between second primary malignancies and postoperative radiotherapy in young-onset breast cancer patients. by Yulin Lai, Peiyuan Huang

    Published 2025-01-01
    “…<h4>Background</h4>A second primary malignant tumor is one of the most important factors affecting the long-term survival of young women with breast cancer (YWBC). As one of the main treatments for breast cancer YWBC patients, postoperative radiotherapy (PORT) may increase the risk of second primary malignancy (SPM).…”
    Get full text
    Article
  9. 469

    Impact of corticosteroids on the efficacy of first-line pembrolizumab plus chemotherapy in patients with advanced non-small-cell lung cancer by Amytis Roboubi, Eric Wasielewski, Soraya Bordier, Amélie Turlotte, Geoffrey Pavaut, Arnaud Scherpereel, Alexis Cortot, Clément Gauvain

    Published 2025-02-01
    “…Background: Systemic corticosteroids (SCs) are associated with reduced survival in patients with advanced non-small-cell lung cancer (NSCLC) receiving immune checkpoint inhibitor (ICI) monotherapy. …”
    Get full text
    Article
  10. 470

    NOS2 as a prognostic biomarker for early-onset colorectal cancer based on public data and clinical validation analysis by Chaoqun Xing, Lipeng Zhao, Weiwei Zou, Xie Peng, Xiao-Liang Xing, Jie Li

    Published 2025-02-01
    “…Abstract Early-onset colorectal cancer (EOCRC) was characterized by strong aggressiveness and high malignancy. …”
    Get full text
    Article
  11. 471
  12. 472
  13. 473

    Associations between phenol and paraben exposure and the risk of developing breast cancer in adult women: a cross-sectional study by Yao Xiong, Zhiyu Li, Xiong Xiong, Zixuan Luo, Kaixin Zhong, Jiawei Hu, Shengrong Sun, Chuang Chen

    Published 2025-02-01
    “…Abstract Increasing evidence suggests that endocrine-disrupting chemicals (EDCs) have adverse effects on breast cancer (BC). The aim of this study was to assess the association between exposure to prevalent EDCs—phenols and parabens—and the risk of developing BC. …”
    Get full text
    Article
  14. 474
  15. 475
  16. 476

    Cost Effectiveness Analysis of Eribulin Mesylate as a Treatment for Metastatic Breast Cancer in Spain: Management in the Later Line of Therapy by Gabriel Tremblay, Unnati Majethia, Ilias Kontoudis, Jesús De Rosendo

    Published 2015-10-01
    “…**Background:** Two thirds (62%) of metastatic breast cancer (MBC) patients in Western Europe have human epidermal growth factor receptor 2 (HER2)-negative disease, for which anthracyclines and taxanes are recommended as first-line treatments, followed by microtubule-targeting agents such as capecitabine, vinorelbine and/or eribulin. …”
    Get full text
    Article
  17. 477
  18. 478
  19. 479
  20. 480